EGLN1, Human, 重组蛋白 (His & Myc)-有机试剂-试剂-生物在线
TargetMol中国
EGLN1, Human, 重组蛋白 (His & Myc)

EGLN1, Human, 重组蛋白 (His & Myc)

商家询价

产品名称: EGLN1, Human, 重组蛋白 (His & Myc)

英文名称: EGLN1 Protein, Human, Recombinant (His & Myc)

产品编号: TMPH-01280

产品价格: 100 μg

产品产地: 美国

品牌商标: TargetMol

更新时间: 2024-05-23T17:34:14

使用范围: null

规格 价格
3420.00
TargetMol中国
  • 联系人 : 邵雪香
  • 地址 : 上海市静安区江场三路238号8楼
  • 邮编 : 200436
  • 所在区域 : 上海
  • 电话 : 150****4094 点击查看
  • 传真 : 点击查看
  • 邮箱 : sales@targetmol.com
  • 二维码 : 点击查看

Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF1B. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. EGLN1 is the most important isozyme under normoxia and, through regulating the stability of HIF1, involved in various hypoxia-influenced processes such as angiogenesis in retinal and cardiac functionality. Target proteins are preferentially recognized via a LXXLAP motif.